Product Information
GLIPIZIDE-METFORMIN 2.5-250 MG is a generic product labeled by Chartwell RX LLC, priced at $0.3003 per EA under NDC 62135073160. Its NADAC has been published 120 times since Mar 13, 2024.
Strength
2.5; 250 mg/1; mg/1
Manufacturer
Chartwell RX LLCNDC
62135073160
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GLIPIZIDE; METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078728On Market Since
6/29/2010
Pharmacological Classes
Price Statistics
The NADAC for GLIPIZIDE-METFORMIN 2.5-250 MG has been published 120 times since Mar 13, 2024, and over the history we have for it it has risen 21.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3003 per EA |
|---|---|
| All-time high | $0.3003 (Jun 24, 2026) |
| All-time low | $0.1748 (Nov 19, 2025) |
| 52-week high | $0.3003 |
| 52-week low | $0.1748 |
| Median price | $0.2407 |
| Average price | $0.2367 |
| Largest weekly change | +16.8% (Nov 20, 2024) |
| Weeks tracked | 120 |
| Tracking since | Mar 13, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Glipizide and metformin hcl market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of GLIPIZIDE-METFORMIN 2.5-250 MG?
The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE-METFORMIN 2.5-250 MG, manufactured by Chartwell RX LLC, is $0.3003 per EA (NDC 62135073160), effective Jun 24, 2026.
How has the price of GLIPIZIDE-METFORMIN 2.5-250 MG changed over time?
Over the history we have for it, the NADAC for GLIPIZIDE-METFORMIN 2.5-250 MG has risen 21.1%. It has been tracked across 120 weekly CMS publications since Mar 13, 2024.
What are the highest and lowest recorded NADAC prices for GLIPIZIDE-METFORMIN 2.5-250 MG?
Since Mar 13, 2024, the NADAC for GLIPIZIDE-METFORMIN 2.5-250 MG has ranged from a low of $0.1748 (Nov 19, 2025) to a high of $0.3003 (Jun 24, 2026), with a median of $0.2407 per EA.
Are there cheaper alternatives to GLIPIZIDE-METFORMIN 2.5-250 MG?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of GLIPIZIDE-METFORMIN 2.5-250 MG, so no direct lower-cost alternative is listed.
Who manufactures GLIPIZIDE-METFORMIN 2.5-250 MG?
GLIPIZIDE-METFORMIN 2.5-250 MG (NDC 62135073160) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification